STOCK TITAN

Point72 (ANGO) reports 3.18M shares, 7.7% stake via Point72 Associates

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

AngioDynamics, Inc. Schedule 13G/A: Point72 reports beneficial ownership of 3,181,829 shares of common stock, representing 7.7% of the class as of March 31, 2026. The shares are held by Point72 Associates; voting and dispositive power are reported as shared. Point72 Asset Management and Point72 Capital Advisors Inc. state they own no shares directly; Steven A. Cohen is reported to control the filing entities.

Positive

  • None.

Negative

  • None.

Insights

Point72 holds a 7.7% passive stake in AngioDynamics as of March 31, 2026.

Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen report 3,181,829 shares beneficially owned via Point72 Associates. The filing lists shared voting and dispositive power for the reported shares.

Cash‑flow treatment and plans for disposition are not disclosed in the excerpt; subsequent filings would state any changes in holdings or voting intentions.

Filing clarifies control relationships among reporting persons.

Point72 Capital Advisors Inc. is stated as general partner of Point72 Asset Management; Mr. Cohen is described as controlling those entities. The statement includes the conventional disclaimer about constructive beneficial ownership under Section 13.

No schedules of trading intentions or plan disclosures are included in the provided excerpt.

Beneficial ownership 3,181,829 shares as of March 31, 2026
Percent of class 7.7% percentage of common stock reported
CUSIP 03475V101 AngioDynamics common stock identifier
Filing signatory date 05/15/2026 signature dates on amendment
beneficially owned regulatory
"Amount beneficially owned: The information required by Item 4(a) is set forth"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 3,181,829.00"
investment management agreement financial
"Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.
general partner corporate
"Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management"
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Point72 hold in AngioDynamics (ANGO)?

Point72 reports beneficial ownership of 3,181,829 shares, equal to 7.7% of common stock as of March 31, 2026. The shares are held via Point72 Associates and reported with shared voting and dispositive power.

Who is the reporting person on the Schedule 13G/A for ANGO?

The filing is made by Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen. Point72 Capital Advisors Inc. is the general partner and Mr. Cohen is stated to control the entities named.

Do the reporting persons claim sole voting or dispositive power for the shares?

No. The cover data and Item 4 report 0 sole voting and dispositive power and 3,181,829 shares of shared voting and shared dispositive power as of March 31, 2026.

Are the shares reported directly owned by Point72 Asset Management or Mr. Cohen?

The filing states Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own no shares directly; the shares are held by an investment fund, Point72 Associates, which Point72 Asset Management manages.

Does the Schedule 13G/A disclose any plans to sell or buy additional ANGO shares?

The provided excerpt does not disclose any purchase or sale plans or describe trading intentions. It reports beneficial ownership and control relationships as of March 31, 2026 without listing dispositions or acquisition plans.





03475V101

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026